
    
      PROTOCOL OUTLINE: This is a randomized study. Patients are randomized to one of two treatment
      arms.

      Arm I: Patients receive oral hydroxyurea and oral clotrimazole daily for 12 months.

      Arm II: Patients receive oral hydroxyurea daily for 12 months. Patients are followed at 6
      weeks.

      Completion date provided represents the completion date of the grant per OOPD records
    
  